News 27 Jul 2022 Daxor Corporation Announces a 49.4% Increase In Its Single-Use Diagnostic Kits Year-Over-Year and Further Acquisitions of its BVA-100® Blood Volume Analyzer by Leading Medical Centers Throughout the U.S. admin
News 21 Jul 2022 Daxor Corporation Announces Partnership with MedAxiom to Advance Awareness & Further Adoption of Daxor’s Blood Volume Diagnostic (BVA-100®) admin
News 18 Jul 2022 Daxor Completes NIH Funded I-Corps Program for Commercialization of Clinical Decision Support Software admin
News 27 Jun 2022 Daxor Announces Cooperative Research & Development Phase II Agreement with the Uniformed Armed Services University for the Development of a Non-Nuclear Blood Volume Analysis (BVA) Device admin
News 13 Jun 2022 Daxor Corporation to Showcase the Benefits of BVA-100® Guided-Care at the American Association of Heart Failure Nurses (AAHFN) 18th Annual Meeting admin
News 25 May 2022 Daxor’s Blood Volume Analyzer (BVA-100®) To Be Used As a Key Metric in Study of “Long Hauler” COVID-19 Patients admin
News 12 May 2022 Daxor Corporation to Present at the H.C. Wainwright & Company Global Investment Conference admin
News 02 May 2022 New Data Validates Blood Volume Analysis Guided-Care, Improves Survival in Patients with Advanced Heart Failure Supported with Left Ventricular Assist Device admin
News 06 Apr 2022 New Study from Duke Heart Demonstrates the Unique Accuracy and Utility of Daxor’s Blood Volume Diagnostic (BVA-100®) for Improving Worsening Heart Failure admin
News 23 Mar 2022 Daxor Corporation to Participate in the Maxim Group 2022 Virtual Growth Conference admin
